Shruti Sheth
Overview
Explore the profile of Shruti Sheth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saboo B, Kesavadev J, Shankar A, Krishna M, Sheth S, Patel V, et al.
Heliyon
. 2021 Jan;
7(1):e05967.
PMID: 33506132
Time-in-range emerged as a valuable blood glucose metric, 'beyond HbA1c' for a deeper insight into glycemic control in people with diabetes. It denotes the proportion of time that a person's...
2.
Nwachukwu C, Mudasiru O, Million L, Sheth S, Qamoos H, Onah J, et al.
J Glob Oncol
. 2018 Dec;
4:1-9.
PMID: 30532992
Purpose: Despite recognition of both the growing cancer burden in low- and middle-income countries and the disproportionately high mortality rates in these settings, delivery of high-quality cancer care remains a...
3.
Vidal G, Chen M, Sheth S, Svahn T, Guardino E
Clin Breast Cancer
. 2017 Apr;
17(6):418-426.
PMID: 28385537
Background: The mammalian target of rapamycin (mTOR) pathway is a driver of breast tumorigenesis. The mTOR inhibitor everolimus reverses antihormonal therapy resistance and is an approved therapy for metastatic breast...
4.
Che J, Yu V, Dhar M, Renier C, Matsumoto M, Heirich K, et al.
Oncotarget
. 2016 Feb;
7(11):12748-60.
PMID: 26863573
Circulating tumor cells (CTCs) are emerging as rare but clinically significant non-invasive cellular biomarkers for cancer patient prognosis, treatment selection, and treatment monitoring. Current CTC isolation approaches, such as immunoaffinity,...
5.
Powell A, Talasaz A, Zhang H, Coram M, Reddy A, Deng G, et al.
PLoS One
. 2012 May;
7(5):e33788.
PMID: 22586443
Background: To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with solid tumors and may...
6.
Berkelhammer C, Patel N, Chen J, Sheth S, Stein R, Ambrose S
J Gastroenterol Hepatol
. 2007 Sep;
22(10):1695-6.
PMID: 17845701
No abstract available.